Clinical Trial Update: Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO) [NA]

View source ↗

Summary

The APOLLO study evaluating INVICTA Ventricular DF4 active-fixation leads has completed. It investigates safety and performance in patients with ventricular arr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Arrhythmia

Snippet

Sponsor: MicroPort CRM | Conditions: Ventricular Arrythmia, Lead | NA | Status: COMPLETED